CA1059123A - Rifamycin compounds - Google Patents

Rifamycin compounds

Info

Publication number
CA1059123A
CA1059123A CA254,253A CA254253A CA1059123A CA 1059123 A CA1059123 A CA 1059123A CA 254253 A CA254253 A CA 254253A CA 1059123 A CA1059123 A CA 1059123A
Authority
CA
Canada
Prior art keywords
carbon atoms
less
alkyl
group
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA254,253A
Other languages
English (en)
French (fr)
Inventor
Leonardo Marsili
Vittorio Rossetti
Carmine Pasqualucci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ARCHIFAR LABORATORI CHIMICO FARMACOLOGICI SpA
Original Assignee
ARCHIFAR LABORATORI CHIMICO FARMACOLOGICI SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ARCHIFAR LABORATORI CHIMICO FARMACOLOGICI SpA filed Critical ARCHIFAR LABORATORI CHIMICO FARMACOLOGICI SpA
Application granted granted Critical
Publication of CA1059123A publication Critical patent/CA1059123A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA254,253A 1975-06-13 1976-06-07 Rifamycin compounds Expired CA1059123A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT755174A IT1056272B (it) 1975-06-13 1975-06-13 Prodotti derivati dalle amine aromatiche

Publications (1)

Publication Number Publication Date
CA1059123A true CA1059123A (en) 1979-07-24

Family

ID=11118842

Family Applications (1)

Application Number Title Priority Date Filing Date
CA254,253A Expired CA1059123A (en) 1975-06-13 1976-06-07 Rifamycin compounds

Country Status (28)

Country Link
US (2) US4086225A (enExample)
JP (1) JPS5236683A (enExample)
AR (1) AR211127A1 (enExample)
AU (1) AU497602B2 (enExample)
BE (1) BE842883A (enExample)
CA (1) CA1059123A (enExample)
CH (1) CH625524A5 (enExample)
CS (1) CS197271B1 (enExample)
DK (1) DK145228C (enExample)
ES (1) ES449187A1 (enExample)
FI (1) FI60208C (enExample)
FR (1) FR2314189A1 (enExample)
GB (1) GB1542063A (enExample)
HK (1) HK56083A (enExample)
HU (1) HU171396B (enExample)
IE (1) IE42998B1 (enExample)
IL (1) IL49701A (enExample)
IN (1) IN143526B (enExample)
IT (1) IT1056272B (enExample)
NL (1) NL177919C (enExample)
NO (1) NO148848C (enExample)
PH (1) PH16410A (enExample)
PL (1) PL99493B1 (enExample)
PT (1) PT65208B (enExample)
SE (1) SE434057B (enExample)
SU (1) SU680649A3 (enExample)
YU (1) YU39768B (enExample)
ZA (1) ZA763256B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1056272B (it) * 1975-06-13 1982-01-30 Archifar Ind Chim Trentino Prodotti derivati dalle amine aromatiche
DK345977A (da) * 1976-09-30 1978-03-31 Archifar Ind Chim Trentino G rifamycinforbindelser og fremgangsmaade til deres fremstillin
BE886395A (fr) * 1980-02-13 1981-03-16 Erba Farmitalia Derives de rifamycine
IT1201963B (it) * 1983-03-24 1989-02-02 Prodotti Antibiotici Spa Derivati delle rifamicine e procedimento per la loro preparazione
US4631290A (en) * 1985-08-29 1986-12-23 American Home Products Corporation Method of treating hepatitis
DE69400631T2 (de) * 1993-05-05 1997-02-27 Palo Alto Medical Foundation, Palo Alto, Calif. Verwendung von rifamycinderivaten zur herstellung eines arzneimittels zur behandlung der toxoplasmose
US5529994A (en) * 1993-05-05 1996-06-25 Palo Alto Medical Foundation Treatment for toxoplasmosis
US5981522A (en) * 1995-09-01 1999-11-09 Kaneka Corporation Treatment of disease caused by infection of Helicobacter
EP0787494B1 (en) * 1995-09-01 2004-06-09 Kaneka Corporation Use of rifamycin derivatives for the manufacture of a medicament for the treatment of diseases caused by infections of helicobacter pylori
JP2005510534A (ja) * 2001-11-21 2005-04-21 アクティブバイオティクス インコーポレイティッド 標的化治療薬およびその使用
WO2003051299A2 (en) * 2001-12-13 2003-06-26 Activbiotics, Inc. Sulfhydryl rifamycins and uses thereof
US7820652B2 (en) * 2003-09-24 2010-10-26 Activbiotics Pharma, Llc Regimen for the administration of rifamycin-class antibiotics
US7202246B2 (en) * 2004-06-09 2007-04-10 Cumbre Pharmaceuticals Inc. Spiro-rifamycin derivatives targeting RNA polymerase
ES2246155B1 (es) * 2004-07-19 2007-03-16 Universidad De Oviedo Nuevas espiropiperidilrifamicinas.
EP1928890B1 (en) 2005-08-11 2013-04-03 Targanta Therapeutics Inc. Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
WO2008008480A2 (en) * 2006-07-12 2008-01-17 Cumbre Pharmaceuticals Inc. Nitroheteroaryl-containing rifamycin derivatives
CN100569778C (zh) * 2006-12-05 2009-12-16 四川明欣药业有限责任公司 一种利福布汀结晶工艺
WO2009064792A1 (en) * 2007-11-16 2009-05-22 Cumbre Pharmaceuticals Inc. Quinolone carboxylic acid-substituted rifamycin derivatives
US8524691B2 (en) 2008-08-13 2013-09-03 The Medicines Company Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
MX370688B (es) 2012-08-30 2019-12-19 Texas A & M Univ Sys Composiciones y métodos para sensibilización con fármaco o inhibición de una célula de cáncer.
PH12013000351A1 (en) 2013-11-22 2015-05-25 Joselle A Macrohon A versatile queuing management system and method
JP6867288B2 (ja) 2014-07-21 2021-04-28 エーエムディー セラピューティックス エルエルシー リファマイシンの眼科用組成物およびその使用
CN106279205B (zh) * 2015-05-12 2020-07-21 重庆华邦胜凯制药有限公司 制备利福霉素s衍生物的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130099C (enExample) * 1963-10-11
IT1056272B (it) * 1975-06-13 1982-01-30 Archifar Ind Chim Trentino Prodotti derivati dalle amine aromatiche
DE2626296C2 (de) * 1975-06-13 1986-11-27 Farmitalia Carlo Erba S.p.A., Mailand/Milano Rifamycin-Verbindung und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
PL99493B1 (pl) 1978-07-31
FI60208C (fi) 1981-12-10
HU171396B (hu) 1978-01-28
GB1542063A (en) 1979-03-14
IT1056272B (it) 1982-01-30
IL49701A0 (en) 1976-08-31
BE842883A (fr) 1976-10-01
SU680649A3 (ru) 1979-08-15
US4086225A (en) 1978-04-25
DK145228C (da) 1983-02-28
FR2314189A1 (fr) 1977-01-07
YU39768B (en) 1985-04-30
FI761688A7 (enExample) 1976-12-14
FI60208B (fi) 1981-08-31
AU497602B2 (en) 1978-12-21
IN143526B (enExample) 1977-12-17
NL7606370A (nl) 1976-12-15
JPS6121957B2 (enExample) 1986-05-29
NO762026L (enExample) 1976-12-14
ZA763256B (en) 1977-05-25
DK258076A (da) 1976-12-14
US4219478A (en) 1980-08-26
AR211127A1 (es) 1977-10-31
IE42998L (en) 1976-12-13
PT65208A (en) 1976-07-01
YU140576A (en) 1982-06-30
CH625524A5 (enExample) 1981-09-30
HK56083A (en) 1983-11-25
SE7606640L (sv) 1976-12-14
SE434057B (sv) 1984-07-02
IE42998B1 (en) 1980-12-03
PT65208B (en) 1977-11-23
NL177919B (nl) 1985-07-16
IL49701A (en) 1979-10-31
JPS5236683A (en) 1977-03-22
NO148848C (no) 1983-12-28
FR2314189B1 (enExample) 1980-10-31
AU1476976A (en) 1977-12-15
NL177919C (nl) 1985-12-16
PH16410A (en) 1983-09-29
NO148848B (no) 1983-09-19
ES449187A1 (es) 1977-07-16
CS197271B1 (en) 1980-04-30
DK145228B (da) 1982-10-11

Similar Documents

Publication Publication Date Title
US4086225A (en) Rifamycin compounds
Reetz et al. Stereoselective synthesis of β‐amino alcohols from optically active α‐amino acids
Bechgaard et al. Synthesis of 1, 3-diselenole-2-selones and-2-thiones
CA1081218A (en) Rifamycin compounds
Barnett et al. Meso-oxidation of some metalloporphyrins
CA1057749A (en) Rifamycin compounds
DE60108126T2 (de) Indolinospiropyranverbindungen und methoden zu ihrer herstellung
CA1053667A (en) Rifamycin compounds of high antibiotic activity
Sera et al. High pressure mediated Diels-Alder reaction of furan with dialkyl (acetoxymethylene) malonate
Capobianchi et al. Quantitative Evaluation of Template Effect in the Formation of Cyclobis (paraquat-p-phenylene)
GB1561300A (en) Rifamycin compounds
El Sekily et al. Reactions of the 3-oxime 2-phenylhydrazone and mixed bishydrazones of dehydro-L-ascorbic acid: Conversion into substituted triazoles and pyrazolinediones
Magdesieva et al. Synthesis of stable selenonium ylides
Branch et al. Structure and absorption spectra of 2-phenacylpyridines—1: Simple derivatives
KR790001261B1 (ko) 리파 마이신 화합물의 제조방법
Garlaschelli et al. MCPBA oxidation of bicyclo [3.3. 0] octane-3, 7-dione: an easy entry to a new functionalized cyclopentanoid building block
EP2964645B1 (en) Process for ixabepilone, and intermediates thereof
KR820000498B1 (ko) 리파마이신 화합물의 제조방법
KR810000103B1 (ko) 리파마이신 화합물의 제조방법
Borovkov et al. Synthesis of a triad molecular system containing the photosensitizer mesoporphyrin II and a secondary electron donor and acceptor for modeling the photosynthesis process
Lorincz et al. Ring Enlarging Dipolar Cycloadditions of Chlorosulfonylisocyanate to Epoxides
US3880839A (en) Process for the preparation of rifamycin 5 and analogs thereof from the halomicins
Joseph et al. Reaction of Chlorosulfonyl Isocyanate With 1, 2-Diols: Rearrangement and Formation of Carbonates
Stoodley et al. Studies related to penicillins. Part XI. Mechanism of degradation of benzylpenicillinic and phenoxymethylpenicillinic acid by mercury (II) acetate
Itoh et al. THE SYNTHESIS OF 5-SUBSTITUTED 1, 2, 3,-TRIAZINES WITH KETENE SILYL ACETALS AND CERIC AMMONIUM NITRATE